Catalyst Wire Dossier Catalyst Wire Dossier

Losmapimod

losmapimod · Fulcrum Therapeutics
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Losmapimod, covering 2015-03-17 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension [Phase 2]

See pricing